Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.56
Bid: 4.30
Ask: 4.80
Change: 0.14 (3.17%)
Spread: 0.50 (11.628%)
Open: 4.16
High: 4.56
Low: 4.16
Prev. Close: 4.41
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant progress in SA 2013 maize crop season

13 Sep 2012 07:00

RNS Number : 1343M
Plant Health Care PLC
13 September 2012
 



 

13 September 2012

 

Plant Health Care plc

("Plant Health Care" or "the Company")

Significant increase in hectares being treated in the SA 2013 maize crop season

Plant Health Care plc, a leading provider of novel patent protected biological products to the global agriculture markets, is pleased to announce that Insect Science, Ltd ("Insect Science"), its South African distributor for Harpin and Myconate, has reported significant progress with its Harpin foliar and Myconate seed treatment programmes for the 2013 maize crop season.

In 2013, its second crop season, Insect Science is increasing the number of maize crop hectares it plans to treat with its foliar Harpin product by 567% to 100,000 hectares, or 4.5% of the total South African maize crop (2012: 15,000 hectares). Additionally it plans to increase the number of hectares treated with its Myconate seed treatment by 200% to 60,000 hectares or 2.7% of the total South African maize crop (2012: 20,000 hectares).

John Brady, CEO of Plant Health Care, commented: "Insect Science has made substantial progress into our target market of foliar applied Harpin as well as seed treated with Myconate. In only its second year of the programme they have achieved significant market penetration in the very important maize crop in South Africa. We believe, based on very successful historical maize crop yield increases of approximately 6.5%, that we will continue to experience significant growth in the coming years."

Charlie Bender, Marketing and Product Development Director of Insect Science, Ltd commented: "We are very pleased with the rapid growth we are experiencing with the Plant Health Care products. A significant portion of South African potatoes and pears crops are already treated with these products and we anticipate a similar growth pattern in the maize crop as well. Farmers have seen strong yield increases with this programme which has significantly enhanced their bottom lines."

- ENDS -

 

About Plant Health Care plc: Plant Health Care plc ("Plant Health Care") is a leading provider of novel patent protected biological products to the global agriculture markets. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/ mnemonic: PHC).

Further information is available at: www.planthealthcare.com.

 

 For further information, please contact:

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Stephen Weaver, Finance Director

Tel: +1-412-826-5488 x151

sweaver@planthealthcare.com

Nomura Code Securities

Tel: +44 (0) 20 7776 1200

Clare Terlouw / Chris Golden

www.nomuracode.com

Powerscourt

Tel: +44 (0) 20 7250 1446

Paul Durman / Nick Dibden

paul.durman@powerscourt-group.com

nick.dibden@powerscourt-group.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABUGDCXDBBGDD
Date   Source Headline
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.